Table 11.

Distribution of sMBL levels in cases and controls, stratified on the basis of combined 5′/3′ block haplotypes of MBL2

Haplotypes	Controls		RVVI		p-value (controls vs RVVI)^†	BV		p-value (controls vs BV)^†	VVC		p-value (controls vs VVC)^†	MI		p-value (controls vs MI)^†
Haplotypes	n	Mean ± SD	n	Mean ± SD	p-value (controls vs RVVI)^†	n	Mean ± SD	p-value (controls vs BV)^†	n	Mean ± SD	p-value (controls vs VVC)^†	n	Mean ± SD	p-value (controls vs MI)^†
5′H-10/3′H-2	24	836.70 ± 293.17	23	434.33 ± 190.36^ab	1.7 × 10⁻⁶***	9	466.93 ± 253.23	0.002**	8	348.26 ± 113.77	1.9 × 10⁻⁷***	6	502.68 ± 148.28^d	0.001***
5′H-5/3′H-1	12	957.48 ± 453.28	16	857.95 ± 549.84^a	0.614	9	976.38 ± 598.13	0.935	3	296.06 ± 345.25	0.036*	4	1042.5 ± 282.10^{d e}	0.733
5′H-3/3′H-3	15	1267.1 ± 418.30	10	714.96 ± 513.21	0.007**	4	792.13 ± 657.76	0.090	3	541.73 ± 635.47	0.02*	3	785.30 ± 260.96	0.076
5′H-1/3′H-1	14	1261.6 ± 612.37	10	795.10 ± 425.08	0.050*	10	795.10 ± 425.08	0.050*	0	0.00 ± 0.00	NA	0	0.00 ± 0.00	NA
5′H-9/3′H-1	15	1228.8 ± 545.30	8	729.92 ± 407.04	0.034*	4	788.98 ± 463.87	0.160	2	796.85 ± 645.86	NA	2	544.88 ± 75.72	NA
5′H-1/3′H-2	9	999.78 ± 162.15	11	969.51 ± 530.29^bc	0.861	4	1113.4 ± 138.52	0.251	5	934.80 ± 788.63	0.864	2	768.50 ± 311.79	NA
5′H-35/3′H-3	4	1070.9 ± 362.48	11	389.29 ± 194.90^c	3.6 × 10⁻⁴***	5	363.78 ± 281.19	0.013*	3	346.46 ± 51.56	0.026*	3	466.14 ± 127.39^e	0.042*
5′H-60/3′H-1	3	915.49 ± 320.84	11	735.61 ± 320.19	0.405	7	578.27 ± 174.35	0.057	3	576.38 ± 110.23	0.158	1	1159.05 ± 0.00	NA
p-value^††		0.032*		0.002**			0.050*			0.269			0.006**

Haplotypes with n < 3 are not included in statistical analysis

* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001

^†Independent t-test between patients and controls as well as within groups

^††One Way ANOVA with overall p-value followed by Post Hoc Tukey test that further indicates values with similar letter are significantly different

^ap = 0.033, ^b p = 0.010, ^c p = 0.021, ^d p = 0.008, ^e p = 0.016